{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:56:07Z","timestamp":1782320167414,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd000977","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000}}],"reference-count":59,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000977.pub2","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T15:52:56Z","timestamp":1233676376000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Vaccines for preventing tick-borne encephalitis"],"prefix":"10.1002","author":[{"given":"Vittorio","family":"Demicheli","sequence":"first","affiliation":[{"name":"Regione Piemonte - Azienda Sanitaria Locale ASL AL; Health Councillorship - Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi-SeREMI - Cochrane Vaccines Field; C.so Regina Margherita 153 bis Torino Piemonte Italy 10122"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Debalini","sequence":"additional","affiliation":[{"name":"ASL 20 Alessandria; Cochrane Vaccines Field; via Venezia 6 Alessandria Italy 15100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rivetti","sequence":"additional","affiliation":[{"name":"Azienda Sanitaria Locale ASL AL; Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi-SeREMI - Cochrane Vaccines Field; Via Venezia 6 Alessandria Piemonte Italy 15100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD000977.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0264-410X(90)90172-I","article-title":"A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study","volume":"8","author":"Bock","year":"1990","journal-title":"Vaccine"},{"issue":"25-26","key":"10.1002\/14651858.CD000977.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1016\/S0264-410X(03)00422-5","article-title":"Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children","volume":"21","author":"Eder","year":"2003","journal-title":"Vaccine"},{"issue":"25-26","key":"10.1002\/14651858.CD000977.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1016\/S0264-410X(03)00422-5","article-title":"Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children","volume":"21","author":"Eder","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD000977.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0264-410X(03)00563-2","article-title":"Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity","volume":"22","author":"Ehrlich","year":"2003","journal-title":"Vaccine"},{"issue":"15","key":"10.1002\/14651858.CD000977.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0264-410X(96)00081-3","article-title":"Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study","volume":"14","author":"Girgsdies","year":"1996","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD000977.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0264-410X(92)90003-3","article-title":"A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens","volume":"10","author":"Harabacz","year":"1992","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0007|cit7","unstructured":"Immuno AG A double-blind study designed to investigate the immunogenicity of three TBE vaccines 1996. Unpublished"},{"issue":"24","key":"10.1002\/14651858.CD000977.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/j.vaccine.2006.03.061","article-title":"Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies","volume":"24","author":"Loew-Baselli","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD000977.pub2-BIB0009|cit9","first-page":"50","article-title":"A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents","author":"Pavlova","year":"1999","journal-title":"Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii"},{"issue":"2","key":"10.1002\/14651858.CD000977.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/hv.3.2.3747","article-title":"Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21)","volume":"3","author":"Schoendorf","year":"2007","journal-title":"Human Vaccines"},{"issue":"8","key":"10.1002\/14651858.CD000977.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.vaccine.2006.10.028","article-title":"Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule","volume":"25","author":"Sch\u00f6ndorf","year":"2007","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0264-410X(02)00815-0","article-title":"A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis","volume":"21 Suppl 1","author":"Baumhackl","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD000977.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4269\/ajtmh.1999.61.874","article-title":"An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia","volume":"61","author":"Craig","year":"1999","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"7-8","key":"10.1002\/14651858.CD000977.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0264-410X(98)00272-2","article-title":"Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients","volume":"17","author":"Dengler","year":"1999","journal-title":"Vaccine"},{"issue":"8","key":"10.1002\/14651858.CD000977.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0264-410X(94)00032-I","article-title":"Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events","volume":"13","author":"Hedenstr\u00f6m","year":"1995","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD000977.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.vaccine.2006.09.014","article-title":"Evaluation of vaccine Encepur Adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus","volume":"25","author":"Leonova","year":"2007","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0017|cit17","first-page":"208","article-title":"Placebo controlled EEG double blind study with the further purified TBE-vaccine","volume-title":"Tick-borne encephalitis","author":"Mamoli","year":"1981"},{"issue":"1","key":"10.1002\/14651858.CD000977.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s15010-002-2020-6","article-title":"Immunological response in HIV-positive patients vaccinated against tick-borne encephalitis","volume":"31","author":"Panasiuk","year":"2003","journal-title":"Infection"},{"issue":"1","key":"10.1002\/14651858.CD000977.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0197-2456(95)00261-8","article-title":"Can we reduce the dose of a vaccine?","volume":"18","author":"Rosenkranz","year":"1997","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijmm.2006.01.009","article-title":"Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule","volume":"296 Suppl 40","author":"Sch\u00f6ndorf","year":"2006","journal-title":"International Journal of Medical Microbiology"},{"issue":"2","key":"10.1002\/14651858.CD000977.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2006.07.026","article-title":"Study of the serological response after vaccination against tick-borne encephalitis in Sweden","volume":"25","author":"Vene","year":"2007","journal-title":"Vaccine"},{"issue":"32","key":"10.1002\/14651858.CD000977.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.vaccine.2003.08.005","article-title":"Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD000977.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jmv.1890190109","article-title":"Different immune responses after intradermal and intramuscular administration of vaccine against tick-borne encephalitis virus","volume":"19","author":"Zoulek","year":"1986","journal-title":"Journal of Medical Virology"},{"issue":"6","key":"10.1002\/14651858.CD000977.pub2-BIB0024|cit24","first-page":"34","article-title":"A study of the reactogenic and antigenic potency of dried chromatographic purified concentrated inactivated dried vaccine against tick-borne encephalitis","author":"Popov","year":"1985","journal-title":"Zhurnal Mikrobiologii Epidemiologii, i Immunobiologii"},{"issue":"7","key":"10.1002\/14651858.CD000977.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.vaccine.2007.12.015","article-title":"Evaluation of the Langat\/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers","volume":"26","author":"Wright","year":"2008","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0026|cit26","unstructured":"NCT00118924 Phase 1 study of the safety and immunogenicity of tick-borne Langat\/Dengue 4 Chimera (LGT(TP21)\/DEN4), a live attenuated vaccine for tick-borne encephalitis clinicaltrials.gov\/show\/NCT00118924"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0027|cit27","article-title":"Multicentre randomized double-blind Phase II\/III study on the safety and immunogenicity of three vaccinations With TICOVAC in two dosages in healthy children aged between six months and three years","author":"NCT00161746","journal-title":"clinicaltrials.gov\/show\/NCT00161746"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0028|cit28","unstructured":"NCT00161772 Double-blind, randomized, multicenter dose-finding study to investigate the safety and immunogenicity of two vaccinations with FSME IMMUN NEW in healthy volunteers aged 1 to 6 years clinicaltrials.gov\/show\/NCT00161772"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0029|cit29","unstructured":"NCT00161785 Investigation of the seropersistence of TBE antibodies and the booster response to FSME-IMMUN 0.5 ml in adults aged 18 - 67 years clinicaltrials.gov\/show\/NCT00161785"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0030|cit30","unstructured":"NCT00161798 Double-blind, randomized, multicenter dose-finding study to investigate the safety and immunogenicity of two vaccinations with FSME IMMUN NEW in healthy volunteers aged 6 to 16 years clinicaltrials.gov\/show\/NCT00161798"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0031|cit31","unstructured":"NCT00161824 Single-blind, randomized, multicenter comparison of FSME IMMUN NEW and ENCEPUR: safety and tolerability of two vaccinations in healthy volunteers aged 16 to 65 years clinicaltrials.gov\/show\/NCT00161824"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0032|cit32","unstructured":"NCT00161850 Follow-up study to investigate the safety and immunogenicity of a third vaccination with three different antigen concentrations of FSME IMMUN NEW in children aged 1 to 6 years clinicaltrials.gov\/show\/NCT00161850"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0033|cit33","unstructured":"NCT00161889 Follow-up study to investigate the safety and immunogenicity of a third vaccination with three different antigen concentrations of FSME IMMUN NEW in children aged 6 to 16 years clinicaltrials.gov\/show\/NCT00161889"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0034|cit34","article-title":"A Phase IV, randomized, controlled, single-blind, multi-center study in children to evaluate the safety, tolerability and immunogenicity of two TBE vaccines administered according to two different schedules","author":"NCT00311441","journal-title":"clinicaltrials.gov\/ct2\/show\/record\/NCT00311441"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0035|cit35","article-title":"A Phase IV, randomized, open-label, multi-center study in adults: evaluation of long-term immunogenicity in subjects boosted with a new TBE vaccine for adults (free of protein-derived stabilizer) in Study V48P2E1, 5 years after first booster immunization and evaluation of booster kinetics in subjects boosted with a new TBE vaccine for adults (free of protein-derived stabilizer), 5 years after first booster immunization","author":"NCT00311493","journal-title":"clinicaltrials.gov\/show\/NCT00311493"},{"issue":"26","key":"10.1002\/14651858.CD000977.pub2-BIB0036|cit36","article-title":"Tickborne encephalitis in Lithuania.","volume":"8","author":"Asokliene","year":"2004","journal-title":"Eurosurveillance Weekly Release"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0037|cit37","first-page":"773","article-title":"Tick-borne encephalitis vaccine","volume-title":"Vaccines","author":"Barret","year":"1999"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0264-410X(02)00814-9","article-title":"History of TBE vaccines","volume":"21 Suppl 1","author":"Barrett","year":"2003","journal-title":"Vaccine"},{"issue":"26","key":"10.1002\/14651858.CD000977.pub2-BIB0039|cit39","article-title":"Tickborne encephalitis in the Czech Republic","volume":"8","author":"Beran","year":"2004","journal-title":"Eurosurveillance Weekly Release"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0040|cit40","article-title":"\"New\" flaviviruses (FV) circulating in S. Germany (abstract)","volume-title":"Symposium on modern approaches to flavivirus vaccines","author":"Clement","year":"1996"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0041|cit41","volume-title":"European Pharmacopoeia 1999 Supplement","author":"Council of Europe","year":"1999"},{"issue":"17","key":"10.1002\/14651858.CD000977.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"18848","DOI":"10.2807\/ese.13.17.18848-en","article-title":"A survey on cases of tick-borne encephalitis in European countries","volume":"13","author":"Donoso Mantke","year":"2008","journal-title":"Eurosurveillance"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80 Pt 1","author":"Ecker","year":"1999","journal-title":"Journal of General Virology"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0264-410X(02)00811-3","article-title":"Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up","volume":"21 Suppl 1","author":"Haglund","year":"2003","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1099\/0022-1317-82-6-1319","article-title":"Distribution and characterization of tick-borne encephalitis viruses from Siberia and far-eastern Asia","volume":"82 Pt 6","author":"Hayasaka","year":"2001","journal-title":"Journal of General Virology"},{"issue":"1","key":"10.1002\/14651858.CD000977.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<102::AID-JMV16>3.0.CO;2-I","article-title":"Correlation between ELISA, haemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis","volume":"48","author":"Holzmann","year":"1996","journal-title":"Journal of Medical Virology"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0264-410X(02)00819-8","article-title":"Diagnosis of tick-borne encephalitis","volume":"21 Suppl 1","author":"Holzmann","year":"2003","journal-title":"Vaccine"},{"issue":"7303","key":"10.1002\/14651858.CD000977.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0049|cit49","unstructured":"Kaiser R Clinical description Tick borne encephalitis (TBE, FSME): Monograph; www.isw-tbe.info\/upload\/medialibrary\/Monograph_TBE.pdf 21 8"},{"issue":"2","key":"10.1002\/14651858.CD000977.pub2-BIB0050|cit50","first-page":"1","article-title":"Tick-borne encephalitis in Europe","volume":"60","author":"Kunz","year":"1992","journal-title":"Acta Leidensia"},{"issue":"6","key":"10.1002\/14651858.CD000977.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.vaccine.2004.07.048","article-title":"Tick borne encephalitis in childhood: conference report and consensus of the International Scientific Working Group on tick-borne encephalitis (ISW-TBE)","volume":"26","author":"Kunze","year":"2004","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0052|cit52","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org"},{"issue":"26","key":"10.1002\/14651858.CD000977.pub2-BIB0053|cit53","article-title":"Tickborne encephalitis in Latvia","volume":"8","author":"Lucenko","year":"2004","journal-title":"Eurosurveillance Weekly Release"},{"issue":"5","key":"10.1002\/14651858.CD000977.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2310\/7060.2004.19107","article-title":"Risk and prevention of tick-borne encephalitis in travelers","volume":"11","author":"Rendi-Wagner","year":"2004","journal-title":"Journal of Travel Medicine"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0055|cit55","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"29","key":"10.1002\/14651858.CD000977.pub2-BIB0056|cit56","article-title":"Tickborne encephalitis in Europe: basic information, country by country","volume":"8","author":"Strauss","year":"2004","journal-title":"Eurosurveillance Weekly Release"},{"key":"10.1002\/14651858.CD000977.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0264-410X(02)00812-5","article-title":"Epidemiology and ecology of TBE relevant to the production of effective vaccines","volume":"21 Suppl 1","author":"S\u00fcss","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD000977.pub2-BIB0058|cit58","first-page":"26","article-title":"Tick-borne encephalitis in the Russian Federation: state-of-the-art and prevention policy","volume":"50","author":"Zlobin","year":"2005","journal-title":"Voprosy Virusologii"},{"issue":"1","key":"10.1002\/14651858.CD000977.pub2-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000977","article-title":"Vaccines for preventing tick-borne encephalitis","author":"Demicheli","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000977.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:09:23Z","timestamp":1633050563000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000977.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":59,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000977.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}